Bill Phillips

Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.

Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.

4Tech Cardio Ireland Ltd. develops and manufactures surgical devices. The company was founded in 2011 and is headquartered in Waltham, MA.

Valiance Advisors LLP is the alternative asset management subsidiary of Valiance Asset Management Ltd. in Great Britain. The firm was founded by Jan Pensaert in 2008. Headquartered in London, Valiance Advisors manages Life Sciences portfolio for individual and institutional investors.

JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE.

MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium.

Pacira Cryotech, Inc. develops novel technologies for treatment of peripheral nerves. Its iovera treatment harnesses the power of cold with the Focused Cold Therapy delivery system and delivers immediate results for both therapeutic and aesthetic applications. The firm’s iovera treatment does not use toxins, chemicals, or pharmaceuticals to achieve results and leaves nothing behind in the body. The company was founded by Lisa Elkins in 2005 and is headquartered in Fremont, CA.

Valiance Life Science Investments (Valiance Life Science Investments) is a private equity subsidiary of Valiance Asset Management Ltd. founded in 2017. The firm headquartered in London, United Kingdom.

Valiance Asset Management Ltd. provides investment services. It offers sovereign funds, pension funds, leading families and individuals investment services. The company was founded by Jan Pensaert in 2008 and is headquartered in St. Peter Port, Guernsey.

Valtech Cardio Ltd. develops devices for mitral valve repair and replacement. It specializes in the development of devices for mitral and tricuspid valve repair and replacement. The firm also offers full in-house development, manufacturing and clinical research capabilities, and patent applications. The company was founded by Amir Gross and Yossi Gross in March 2005 and is headquartered in Or Yehuda, Israel.

Part of Venus Medtech (Hangzhou), Inc., Cardiovalve Ltd. is an Israeli medical device company that specializes in developing the Cardiovalve transcatheter system. The company is based in Or Yehuda, Israel. The system is designed to replace regurgitating mitral and tricuspid valves using a transfemoral-transseptal approach. The CEO of the company is Amir Gross. Cardiovalve was acquired by Athena Medtech Holding Ltd. on January 25, 2022 for $83.98 million.

The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA.

Magenta Medical Ltd. develops medical devices for the treatment of acute and congestive heart failure. It offers a temporary venous catheter-based therapy for hospital-admitted patients. The firm?s novel therapeutic principle is aimed at addressing renal venous congestion and its deleterious effects on renal and cardiac function that is a pathophysiological core element of acute heart failure. The company was founded by Ehud Schwammenthal and Yosi Tuval in October 2012 and is headquartered in Kadima, Israel.